Clinical Trial

Mass Balance Study of [14C] LPM3770164 in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a phase 1, single-center, single-dose, open-label mass-balance study to evaluate radioactive recovery rate, radioactive PK characteristics, metabolite identification, and to observe the safety in healthy male subjects of \[14C\] LPM3770164.
Trial Details
NCT Number NCT07516899
Lead Sponsor Luye Pharma Group Ltd.
Conditions Huntington Disease
Enrollment 8 participants
Start Date 2026-04-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-08